Taylor Swift’s Eras Tour is the first concert tour to gross more than $1B. Jenny Horne analyzes Taylor Swift’s impact on the markets in 2023. She talks about how “Taylor Swift: The Eras Tour” film was released October 13th in theaters and became the highest-grossing concert film of all time. Horne also examines a tough 2023 for Pfizer (PFE) and Moderna (MRNA). She goes over how PFE and MRNA navigate the post-Covid landscape. Tune in to find out more about the stock market today.
The Watch List
02 Jan 2024
SHARE